MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
出版年份 2020 全文链接
标题
MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
作者
关键词
-
出版物
Bioengineered
Volume 11, Issue 1, Pages 91-102
出版商
Informa UK Limited
发表日期
2020-01-07
DOI
10.1080/21655979.2019.1710925
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
- (2019) Tong Liu et al. Molecular Cancer
- Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance
- (2019) Zohreh Rezaei et al. DNA AND CELL BIOLOGY
- Long noncoding RNA MPRL promotes mitochondrial fission and cisplatin chemosensitivity via disruption of pre-miRNA processing
- (2019) Tian Tian et al. CLINICAL CANCER RESEARCH
- MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFβ1/Smad2 signaling pathway in human bladder cancer
- (2019) Xi Chao Wei et al. OncoTargets and Therapy
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling
- (2018) Meng Lu et al. DNA AND CELL BIOLOGY
- miR-132 targets FOXA1 and exerts tumor-suppressing functions in thyroid cancer
- (2018) Xin Chen et al. ONCOLOGY RESEARCH
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5
- (2018) Mingbao Zhang et al. CANCER BIOLOGY & THERAPY
- TGF-β1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression
- (2018) Yijiao Luo et al. GENE
- Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail
- (2017) Hyuk Moon et al. GASTROENTEROLOGY
- MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma
- (2017) Zhen-Xiu Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway
- (2017) Lanfang Zhang et al. MOLECULAR CARCINOGENESIS
- TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis
- (2017) Salih Gencer et al. Science Signaling
- Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins
- (2017) Jin Wang et al. Artificial Cells Nanomedicine and Biotechnology
- TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis
- (2017) Salih Gencer et al. Science Signaling
- MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4
- (2016) Weiwei Fu et al. PROSTATE
- Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
- (2016) Xin Zhang et al. Experimental and Therapeutic Medicine
- miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells
- (2015) Jian-Li Zhao et al. IUBMB LIFE
- MicroRNA-132 enhances transition from inflammation to proliferation during wound healing
- (2015) Dongqing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1
- (2014) Zhan-Guo Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TGF-beta Signaling in Cancer Treatment
- (2014) Isabel Fabregat et al. CURRENT PHARMACEUTICAL DESIGN
- Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-
- (2014) Z. Wiener et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histological and molecular aspects of oral squamous cell carcinoma (Review)
- (2014) CÉSAR RIVERA et al. Oncology Letters
- Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer
- (2013) Lu Lu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Delivering the promise of miRNA cancer therapeutics
- (2012) Diane M. Pereira et al. DRUG DISCOVERY TODAY
- miR-212/132 expression and functions: within and beyond the neuronal compartment
- (2012) A. Wanet et al. NUCLEIC ACIDS RESEARCH
- DNA methylation silences miR-132 in prostate cancer
- (2012) A Formosa et al. ONCOGENE
- miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
- (2011) Jong-Kook Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator
- (2010) Dimitrios Lagos et al. NATURE CELL BIOLOGY
- Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
- (2009) S. Choi et al. JOURNAL OF DENTAL RESEARCH
- MicroRNAs: new regulators of immune cell development and function
- (2008) David Baltimore et al. NATURE IMMUNOLOGY
- Survival following primary surgery for oral cancer
- (2008) Simon N Rogers et al. ORAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started